雪榕生物
(300511)
| 流通市值：14.63亿 | | | 总市值：17.46亿 |
| 流通股本：4.18亿 | | | 总股本：4.99亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 193,090,330.02 | 388,889,617.34 | 647,877,203.54 | 252,666,166.6 |
| 应收票据及应收账款 | 38,452,229.83 | 36,411,414.51 | 31,141,927.37 | 33,480,424.15 |
| 应收账款 | 38,452,229.83 | 36,411,414.51 | 31,141,927.37 | 33,480,424.15 |
| 预付款项 | 9,620,409.02 | 10,374,043.22 | 19,552,724.7 | 19,704,067.38 |
| 其他应收款合计 | 5,708,552.82 | 6,033,140.11 | 8,514,328.36 | 6,279,262 |
| 存货 | 380,976,017.1 | 443,383,926.58 | 479,143,223.23 | 442,863,402.45 |
| 一年内到期的非流动资产 | 4,438,856.73 | 4,291,503.37 | 3,576,677.37 | 3,576,677.37 |
| 其他流动资产 | 7,798,769.44 | 8,166,095.01 | 7,543,844.87 | 8,026,581.27 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 640,085,164.96 | 897,549,740.14 | 1,197,349,929.44 | 766,596,581.22 |
| 非流动资产: | | | | |
| 长期应收款 | 11,360,536.1 | 11,339,888.99 | 14,069,948.89 | 13,925,188.49 |
| 其他非流动金融资产 | 16,240,909.11 | 16,240,909.11 | 16,240,909.11 | 16,240,909.11 |
| 固定资产 | 3,197,625,240.1 | 3,245,986,545.32 | 3,227,331,754.93 | 3,082,273,397.91 |
| 在建工程 | 166,656,322 | 151,646,216.68 | 224,799,392.81 | 360,305,119.09 |
| 使用权资产 | 14,797,956.85 | 15,150,163.71 | 16,126,942 | 17,367,662.11 |
| 无形资产 | 302,497,282.72 | 302,231,454.07 | 304,024,123.58 | 306,897,055.54 |
| 长期待摊费用 | 20,444,218.05 | 21,695,436.25 | 22,543,648.25 | 21,805,756.31 |
| 其他非流动资产 | 15,043,224.99 | 37,411,616.95 | 22,100,812.39 | 16,755,081.56 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,744,665,689.92 | 3,801,702,231.08 | 3,847,237,531.96 | 3,835,570,170.12 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,384,750,854.88 | 4,699,251,971.22 | 5,044,587,461.4 | 4,602,166,751.34 |
| 流动负债: | | | | |
| 短期借款 | 527,169,342.59 | 777,068,655.56 | 878,528,871.09 | 1,035,503,159.89 |
| 应付票据及应付账款 | 264,344,432.66 | 251,654,126.8 | 285,549,604.34 | 318,150,280.61 |
| 其中：应付票据 | 1,426,440.89 | 3,737,278.25 | 2,310,837.36 | 2,310,837.36 |
| 应付账款 | 262,917,991.77 | 247,916,848.55 | 283,238,766.98 | 315,839,443.25 |
| 合同负债 | 6,734,545.47 | 6,598,307.02 | 7,476,587.9 | 7,160,963.44 |
| 应付职工薪酬 | 47,946,508.05 | 47,641,898.64 | 42,314,838.23 | 58,562,726.14 |
| 应交税费 | 8,087,188.92 | 6,982,441.92 | 6,874,034.63 | 5,595,925.66 |
| 其他应付款合计 | 329,326,490.18 | 345,597,863.36 | 342,062,071.59 | 458,761,675.35 |
| 一年内到期的非流动负债 | 215,705,077.94 | 242,559,033.85 | 262,690,317.22 | 229,169,463.18 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,399,313,585.81 | 1,678,102,327.15 | 1,825,496,325 | 2,112,904,194.27 |
| 非流动负债: | | | | |
| 长期借款 | 954,419,831.65 | 977,135,227 | 1,028,749,496.04 | 343,184,757.78 |
| 应付债券 | 623,941,100.87 | 614,578,542.41 | 614,203,816.53 | 605,084,576.03 |
| 租赁负债 | 19,596,630.77 | 18,307,765.18 | 18,029,407.67 | 24,414,732.31 |
| 长期应付款 | 47,694,180.47 | 51,411,693.13 | 55,616,543.88 | 33,077,272.01 |
| 递延收益 | 56,660,079.8 | 58,674,230.93 | 51,738,382.06 | 51,117,204.29 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,702,311,823.56 | 1,720,107,458.65 | 1,768,337,646.18 | 1,056,878,542.42 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,101,625,409.37 | 3,398,209,785.8 | 3,593,833,971.18 | 3,169,782,736.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 498,816,753 | 498,802,073 | 498,780,862 | 498,780,598 |
| 其他权益工具 | 71,130,266.03 | 71,137,697.64 | 71,148,552.65 | 71,148,711.03 |
| 资本公积 | 741,965,631.88 | 741,908,047.01 | 741,823,752.11 | 741,822,492.09 |
| 其他综合收益 | -6,038,790.53 | -6,272,975.77 | -5,490,056.38 | -6,315,197.77 |
| 盈余公积 | 96,221,194.42 | 96,221,194.42 | 96,221,194.42 | 96,221,194.42 |
| 未分配利润 | -10,938,085.39 | 9,277,688.6 | 158,112,113.47 | 152,871,774.28 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,391,156,969.41 | 1,411,073,724.9 | 1,560,596,418.27 | 1,554,529,572.05 |
| 少数股东权益 | -108,031,523.9 | -110,031,539.48 | -109,842,928.05 | -122,145,557.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,283,125,445.51 | 1,301,042,185.42 | 1,450,753,490.22 | 1,432,384,014.65 |
| 负债和股东权益合计 | 4,384,750,854.88 | 4,699,251,971.22 | 5,044,587,461.4 | 4,602,166,751.34 |
| 公告日期 | 2024-10-25 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |